Patents by Inventor Jean-Louis Ruelle

Jean-Louis Ruelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant RSV vaccines
    Patent number: 9492531
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: November 15, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Sonya L. Cyr, Patrick Rheault, Jean-Louis Ruelle
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20160122398
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: January 8, 2016
    Publication date: May 5, 2016
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Jean-Louis Ruelle, Normand Blais, Patrick Rheault
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20150166610
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: October 14, 2013
    Publication date: June 18, 2015
    Inventors: Guy Jean Marie Fernand Pierre BAUDOUX, Jean-Louis Ruelle, Normand Blais, Patrick Rheault
  • Compounds
    Patent number: 8580279
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: November 12, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • Recombinant RSV antigens
    Patent number: 8563002
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: October 22, 2013
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Patrick Rheault, Jean-Louis Ruelle
  • NOVEL COMPOUNDS
    Publication number: 20120328622
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: June 15, 2012
    Publication date: December 27, 2012
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB082 polynucleotides
    Patent number: 8217159
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: July 10, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • RECOMBINANT RSV VACCINES
    Publication number: 20120093847
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 19, 2012
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Sonya L. Cyr, Patrick Rheault, Jean-Louis Ruelle
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20100291147
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: December 23, 2008
    Publication date: November 18, 2010
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Patrick Rheault, Jean-Louis Ruelle
  • NOVEL COMPOUNDS
    Publication number: 20100203057
    Abstract: The invention provides BASB047, BASB054, BASB068 and BASB069 polypeptides, and polynucleotides encoding BASB047, BASB054, BASB068 and BASB069 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 12, 2010
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventor: Jean-Louis Ruelle
  • BASB082 polynucleotides
    Publication number: 20100184139
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 22, 2010
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB082 Polypeptides
    Patent number: 7666988
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: February 23, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB054 polypeptides
    Patent number: 7662399
    Abstract: The invention provides BASB047, BASB054, BASB068 and BASB069 polypeptides, and polynucleotides encoding BASB047, BASB054, BASB068 and BASB069 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: February 16, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventor: Jean-Louis Ruelle
  • BASB019 proteins and genes from , antigens, antibodies, and uses
    Patent number: 7592158
    Abstract: The invention provides BASB019 polypeptides and polynucleotides encoding BASB019 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: September 22, 2009
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventor: Jean-Louis Ruelle
  • Compounds
    Patent number: 7521549
    Abstract: The invention provides BASB041, 43, 44 and 48 polypeptides and polynucleotides encoding BASB041, 43, 44 and 48 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: April 21, 2009
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Jean-Louis Ruelle, Vincent George Christian Louis Verlant
  • BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
    Publication number: 20090093622
    Abstract: The invention provides BASB029 polypeptides and polynucleotides encoding BASB029 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: December 7, 2007
    Publication date: April 9, 2009
    Inventor: Jean-Louis RUELLE
  • BASB034 polypeptides and used thereof
    Patent number: 7432366
    Abstract: Provided are Moraxella catarrhalis BASB034 polypeptides and immunogenic fragments of BASB034 polypeptides. Preferably, the immunogenic fragments have at least 15 amino acids that match an aligned contiguous segment of SEQ ID NOs:2, 4, 6 or 8. The immunogenic fragments, when administered to a subject in a suitable composition (which can include an adjuvant, or a suitable carrier coupled to the fragment) raise an immune response that recognizes a polypeptide having the sequence of SEQ ID NOs:2, 4, 6 or 8. The invention further provides immunogenic compositions containing BASB034 polypeptides and immunogenic fragments thereof, and a pharmaceutically acceptable carrier. Also provided are fusion proteins that contain BASB034 polypeptides and immunogenic fragments thereof.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: October 7, 2008
    Assignee: SmithKline Beecham Biologicals S.A.
    Inventor: Jean-Louis Ruelle
  • Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
    Publication number: 20080219986
    Abstract: The invention provides BASB033 polypeptides and polynucleotides encoding BASB033 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: September 29, 2006
    Publication date: September 11, 2008
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventor: Jean-Louis Ruelle
  • Polypeptides and Polynucleotides "BASB040" From Neisseria Meningitidis and Vaccine Comprising Said Polypeptides and Polynucleotides
    Publication number: 20080057067
    Abstract: The invention provides BASB040 polypeptides and polynucleotides from Neisseria meningitidis encoding BASB040 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylacetic and therapeutic uses.
    Type: Application
    Filed: June 28, 2007
    Publication date: March 6, 2008
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventor: Jean-Louis Ruelle
  • BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
    Publication number: 20070243580
    Abstract: The invention provides BASB019 polypeptides and polynucleotides encoding BASB019 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: March 5, 2004
    Publication date: October 18, 2007
    Applicant: SmithKline Beecham Biologicals S.A.
    Inventor: Jean-Louis Ruelle